Cargando…
A Novel Anti-CD44 Variant 3 Monoclonal Antibody C(44)Mab-6 Was Established for Multiple Applications
Cluster of differentiation 44 (CD44) promotes tumor progression through the recruitment of growth factors and the acquisition of stemness, invasiveness, and drug resistance. CD44 has multiple isoforms including CD44 standard (CD44s) and CD44 variants (CD44v), which have common and unique functions i...
Autores principales: | Suzuki, Hiroyuki, Kitamura, Kaishi, Goto, Nohara, Ishikawa, Kenichiro, Ouchida, Tsunenori, Tanaka, Tomohiro, Kaneko, Mika K., Kato, Yukinari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179237/ https://www.ncbi.nlm.nih.gov/pubmed/37176118 http://dx.doi.org/10.3390/ijms24098411 |
Ejemplares similares
-
Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C(44)Mab-94 against Gastric Carcinomas
por: Suzuki, Hiroyuki, et al.
Publicado: (2023) -
Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C(44)Mab-108 for Immunohistochemistry
por: Suzuki, Hiroyuki, et al.
Publicado: (2023) -
A Novel Anti-CD44 Variant 9 Monoclonal Antibody C(44)Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers
por: Tawara, Mayuki, et al.
Publicado: (2023) -
Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C(44)Mab-18 for Immunohistochemical Analysis against Oral Squamous Cell Carcinomas
por: Ishikawa, Kenichiro, et al.
Publicado: (2023) -
Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C(44)Mab-3 for Multiple Applications against Pancreatic Carcinomas
por: Kudo, Yuma, et al.
Publicado: (2023)